Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H32N2O5 |
Molecular Weight | 368.4678 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O
InChI
InChIKey=IPVQLZZIHOAWMC-QMHWVQJVSA-N
InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13-,14+,15-,16-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
(1''R)-1''-epi-Perindopril is an epimer of the drug perindopril which is commonly used to treat high blood pressure, hypertension, heart failure, or stable coronary artery disease. (1''R)-1''-epe-Perindopril has configuration S, SS, SR and is less active than the parent drug.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
TEM1DRJ22L
Created by
admin on Sat Dec 16 08:30:43 GMT 2023 , Edited by admin on Sat Dec 16 08:30:43 GMT 2023
|
PRIMARY | |||
|
145513-33-3
Created by
admin on Sat Dec 16 08:30:43 GMT 2023 , Edited by admin on Sat Dec 16 08:30:43 GMT 2023
|
PRIMARY | |||
|
5460440
Created by
admin on Sat Dec 16 08:30:43 GMT 2023 , Edited by admin on Sat Dec 16 08:30:43 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD